Monday's Small-Cap Winners & Losers
Siga Technologies (SIGA) jumped 18% after the Food and Drug Administration made an emergency allowance for its ST-246 smallpox drug candidate to treat a child who had been accidentally infected with eczema vaccinatum, a possibly fatal disease with similarities to smallpox. Shares of New York-based Siga were rising 83 cents to $5.35.
Research Frontiers (REFR) was up nearly 15% after selling a nonexclusive license to SmartGlass International for its light-control technology used in windows, skylights, doors and other products. Terms weren't disclosed. Shares of the Woodbury, N.Y., company were gaining $1.30 to $10.22.
Footwear retailer Genesco (GCO) was higher after Women's Wear Daily reported that Foot Locker (FL) is readying a bid of between $44 and $46 a share for the Nashville-based company, which might be announced as early as this week. The publication also reported that Foot Locker isn't ruling out a hostile takeover. Genesco shares were adding $3.25, or 8.2%, to $42.85. Foot Locker was up 2 cents to $22.11.
Cleveland Biolabs (CBLI) slid after announcing it sold $30 million worth of shares in a private placement to accredited investors. Shares were off $1, or 9.9%, to $9.19.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV